文献速递老年综合评估衰弱、肌少症与跌倒多重用药

老年评估驱动的康复转诊模式及其对晚期癌症老年患者功能结局与生存的影响

Exploring geriatric assessment-driven rehabilitation referral patterns and its influence on functional outcomes and survival in older adults with advanced cancer.
PubMed 文献 · J Am Geriatr Soc · 2024-11-02

本研究为一项全国性老年评估(GA)临床试验的二次分析,纳入265例至少有一项GA定义的躯体功能或功能状态受损的晚期癌症老年患者。结果显示,认知受损、Karnofsky评分提示失能及接受单克隆抗体治疗与更高的康复转诊几率相关,而多重用药与更低的转诊几率相关;转诊与3个月内ADL、IADL、HRQoL下降及1年总生存均无独立关联。

要点

  • 认知受损、失能状态及接受单克隆抗体与更高的康复转诊几率相关。
  • 多重用药与更低的康复转诊几率相关。
  • 康复转诊与功能下降、HRQoL及生存均无独立关联。

核心结论

  • 癌症治疗、多重用药、认知及失能状态可能影响肿瘤科医生的康复转诊决策。
  • 康复转诊与功能残疾变化、HRQoL或生存均无独立关联。

研究设计与样本

  • 本研究为全国性老年评估临床试验(NCT020107443,UG1CA189961)的二次分析。
  • 共分析265例至少有一项GA定义的躯体功能或功能状态受损的晚期癌症老年患者。
  • 采用多变量logistic回归和Cox比例风险模型,并以1:1倾向性评分匹配控制人口学与临床因素。

主要发现

  • 认知受损与更高的转诊几率相关(OR=2.25,p=0.01)。
  • Karnofsky评分提示失能与更高的转诊几率相关(OR=2.86,p<0.01)。
  • 接受单克隆抗体与更高的转诊几率相关(OR=1.95,p=0.04)。
  • 多重用药与更低的转诊几率相关(OR=0.31,p<0.01)。
  • 转诊患者ADL下降(OR=0.30,p=0.07)、IADL下降(OR=0.64,p=0.35)、HRQoL下降(OR=1.20,p=0.67)及生存更差(HR=1.18,p=0.62)均无统计学显著性。

临床怎么用

  • 对晚期癌症老年患者进行GA评估时,应关注认知受损、失能状态及多重用药对康复转诊决策的影响。
  • 转诊本身未显示独立改善功能、HRQoL或生存,需进一步评估患者转诊后康复服务的实际利用情况及剂量/时机。

局限性

  • 本研究为二次分析,转诊与结局的探索性分析可能受样本量及未测量混杂因素限制。
  • 未评估患者转诊后康复服务的实际利用情况及康复剂量/时机对结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Older adults with advanced cancer experience functional disability that warrants rehabilitation services; however, evidence indicates inconsistencies in referral. The purpose was to (1) identify predictors of geriatric assessment (GA)-driven referrals to rehabilitation services and (2) explore associations between referral and change in function, health-related quality of life (HRQoL), and overall survival among older adults with advanced cancer. METHODS: This was a secondary analysis (NCT020107443, UG1CA189961) of a nationwide GA clinical trial. Patients were older adults with advanced cancer who had at least one GA-defined physical performance or functional status impairment. Primary outcomes were oncologist-initiated discussion about or referral to rehabilitation services after the GA (Aim 1) and decline in activities of daily living (ADL), Instrumental ADL (IADL), and HRQoL within 3 months, and overall survival at 1 year (Exploratory Aims). Analyses included multivariable logistic regression and Cox proportional hazards models. Demographic and clinical factors were controlled for by using 1:1 propensity score matching. RESULTS: In total 265 patients were analyzed. After adjustment, impaired cognition (odds ratio [OR] = 2.25, p = 0.01), Karnofsky score indicating disability (OR = 2.86, p < 0.01), and receipt of monoclonal antibodies (OR = 1.95, p = 0.04) were associated with higher odds of referral. In contrast, polypharmacy was associated with lower odds of referral (OR = 0.31, p < 0.01). Referred patients were less likely to decline in ADL (OR 0.30, p = 0.07) and IADL (OR 0.64, p = 0.35), but more likely to decline in HRQoL (OR 1.20, p = 0.67) and have worse survival (HR 1.18, p = 0.62). CONCLUSIONS: Cancer treatment, polypharmacy, cognition, and disability status likely influence oncologists' decision to refer for rehabilitation. Referral was not independently associated with change in functional disability, HRQoL, or survival. Future studies should evaluate patients' utilization of rehabilitation services post-referral and determine whether dose/timing of rehabilitation services influence clinical outcomes.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Brick R, Jensen-Battaglia M, Streck BP, et al. Exploring geriatric assessment-driven rehabilitation referral patterns and its influence on functional outcomes and survival in older adults with advanced cancer. J Am Geriatr Soc. 2024. PMID: 39487813. doi:10.1111/jgs.19250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。